Adams Street Partners LLC Adverum Biotechnologies, Inc. Transaction History
Adams Street Partners LLC
- $227 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding ADVM
# of Institutions
5Shares Held
3.6MCall Options Held
0Put Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA2.01MShares$14.4 Million2.99% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.07MShares$7.68 Million0.79% of portfolio
-
Versant Venture Management, LLC San Francisco, CA507KShares$3.64 Million9.99% of portfolio
-
Pinz Capital Management, LP New York, NY15.7KShares$112,7260.03% of portfolio
-
American Portfolios Advisors Holbrook, NY1.15KShares$8,2570.0% of portfolio
About Adverum Biotechnologies, Inc.
- Ticker ADVM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 99,333,600
- Market Cap $713M
- Description
- Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...